Publications by authors named "M A Eldon"

Claim this Profile
S
Safety, Tolerability, and Pharmacokinetics of RT234 (Vardenafil Inhalation Powder): A First-in-Human, Ascending Single- and Multiple-Dose Study in Healthy Subjects.
Michael A Eldon, Edwin L Parsley, Mari Maurer, Thomas E Tarara, Jerry Okikawa

J Aerosol Med Pulm Drug Deliv· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative bioavailability of inhaled treprostinil administered as LIQ861 and Tyvaso® in healthy subjects.
Robert F Roscigno, Toby Vaughn, Ed Parsley, Thomas Hunt, Michael A Eldon

Vascul Pharmacol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Abuse Potential of Oral NKTR-181 in Recreational Opioid Users: A Randomized, Double-Blind, Crossover Study.
Xue Ge, Jack E Henningfield, Suresh Siddhanti, Janet Jobes, Lin Lu, Michael A Eldon

Pain Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated population pharmacokinetics of etirinotecan pegol and its four metabolites in cancer patients with solid tumors.
Sherwin K B Sy, Yen Lin Chia, Toufigh Gordi, Ute Hoch, Michael A Eldon

Cancer Chemother Pharmacol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy.
Deborah Charych, Samira Khalili, Vidula Dixit, Peter Kirk, Thomas Chang, Michael Eldon

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis